Seeking Alpha

Progenics Pharmaceuticals Inc. (PGNX)

We currently have no Breaking News on this stock.
Company Description
Progenics Pharmaceuticals Inc is engaged in the development of medicines for oncology. The Company develops products for the treatment of prostate cancer, opioid-induced constipation, or OIC, as well as OIC for non-cancer pain.
Sector: Healthcare
Industry: Biotechnology
Country: United States